These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 16724293)

  • 1. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
    Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
    J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
    Iagaru A; Quon A; Johnson D; Gambhir SS; McDougall IR
    Mol Imaging Biol; 2007; 9(1):50-7. PubMed ID: 17051322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
    George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
    Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
    Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
    Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
    Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
    J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
    Ishiyama M; Behnia F; Vesselle H
    AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
    Concannon R; Larcos GS; Veness M
    J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
    Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
    Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
    J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
    Yao M; Smith RB; Hoffman HT; Funk GF; Graham MM; Buatti JM
    Am J Clin Oncol; 2005 Apr; 28(2):205-10. PubMed ID: 15803018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
    Epstude M; Tornquist K; Riklin C; di Lenardo F; Winterhalder R; Hug U; Strobel K
    Clin Nucl Med; 2013 Apr; 38(4):283-4. PubMed ID: 23429397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
    Iagaru A; Mittra ES; Gambhir SS
    Mol Imaging Biol; 2011 Apr; 13(2):362-7. PubMed ID: 20495879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
    Lu Y; Fleming SE; Fields RC; Coit DG; Carrasquillo JA
    Clin Nucl Med; 2012 Aug; 37(8):759-62. PubMed ID: 22785503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
    Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
    Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.